Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: A systematic review
Open Access
- 7 December 2024
- journal article
- review article
- Published by Elsevier in New Microbes and New Infections
- Vol. 63, 101551
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2Scientific Reports, 2023
- Association between sex hormones and anti-S/RBD antibody responses to COVID-19 vaccines in healthcare workersHuman Vaccines & Immunotherapeutics, 2023
- Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimensMed, 2023
- SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodiesScience Translational Medicine, 2022
- Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workersJournal of Infection and Chemotherapy, 2022
- Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sexEBioMedicine, 2021
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 MonthsNew England Journal of Medicine, 2021
- SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assaysClinica Chimica Acta, 2021
- Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admissionNature Communications, 2020
- Sex differences in immune responses that underlie COVID-19 disease outcomesNature, 2020